Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.54 |
| ▸ | MAOB | P27338 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | AR | P10275 | 3/20 | 0.44 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19280735 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL6289949 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL16310207 | 0.84 | CYP19A1 (0.54) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL9746473 | 0.83 | CYP19A1 (0.52) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL9746014 | 0.83 | CYP19A1 (0.52) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL1374021 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL31168160 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL5145150 | 0.83 | CYP19A1 (0.67) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL13908822 | 0.81 | CYP19A1 (0.65) | CYP19A1MAOBALDH1A1HPGDAR | |
| SCHEMBL4949955 | 0.81 | ST14 (0.58) | MAOBALDH1A1ST14F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6867200-B1 | (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-15 | — | — | US | disclosed |